The most notable and frequent included NEIL3, XRCC2, CCNO, RAD54L, ATM, DDB2, and MSH2, all of which have been linked to treatment resistance in glioma or solid tumours such as colorectal cancer [10,26,33,34,35,36,37,38]. This evidence concerns the gene XRCC2 and glioma.